Neutral
BVF entities disclose shares, 6.05M pre‑funded warrants in Foghorn (FHTX)
A group of Biotechnology Value Fund (BVF) entities and Mark N. Lampert have disclosed their beneficial ownership in Foghorn Therapeutics Inc. (FHTX) v...